secwatch.observer — SEC 8-K summary
======================================

Issuer:     CVS HEALTH Corp (CVS)
CIK:        0000064803
Form:       8-K
Filed at:   2025-11-20T23:59:59+00:00
Accession:  0001193125-25-289805
Event type: leadership
Sentiment:  positive
Materiality: 0.60
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

CVS Health appoints CEO David Joyner as Chair of the Board effective Jan 1, 2026
--------------------------------------------------------------------------------

- Joyner, President & CEO since Oct 2024, will also serve as Board Chair starting Jan 1, 2026.
- Michael Mahoney continues as Lead Independent Director; Roger Farah remains on the Board.
- Board cites Joyner's nearly 40 years of healthcare experience and operational improvements.
- Joyner leads over 300,000 colleagues; Farah says 'bullish on future' under combined roles.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/64803/000119312525289805/0001193125-25-289805-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/64803/000119312525289805/d172430d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-289805

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer